Related Experiment Video
Updated: Nov 9, 2025
12:31
Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry
Published on: December 8, 2015
15.4K
Quantitative Methods for the Detection of Tau Seeding Activity in Human Biofluids
Aurelien Lathuiliere1,2, Bradley T Hyman1,2
1Alzheimer Research Unit, Department of Neurology, Massachusetts General Hospital, Charlestown, MA, United States.
Frontiers in Neuroscience
|April 8, 2021
Summary
Tau seeds, misfolded tau protein aggregates, are key in Alzheimer's disease (AD) and tauopathies. Detecting these seeds in patients may offer new diagnostic tools for these neurodegenerative conditions.
Area of Science:
- Neuroscience
- Pathology
- Biochemistry
Background:
- Tau aggregates are central to Alzheimer's disease (AD) and tauopathies.
- The propagation of tau seeds across brain regions is a critical pathological mechanism.
- Emerging evidence links tau seed detection in human samples to clinical data.
Purpose of the Study:
- To review current methods for measuring tau seeds.
- To discuss the limitations of existing tau seed detection techniques.
- To explore the potential of tau seeds as next-generation biomarkers for AD and tauopathies.
Main Methods:
- Literature review of studies on tau seed detection methods.
- Analysis of the strengths and weaknesses of various measurement techniques.
- Evaluation of the clinical relevance and biomarker potential of tau seeds.
Main Results:
- Several methods exist for tau seed detection, each with specific limitations.
- Tau seed detection shows promise for correlating with clinical data in AD and tauopathies.
- Further development is needed to optimize these methods for widespread clinical use.
Conclusions:
- Tau seed detection represents a significant advancement in understanding and diagnosing tauopathies.
- Improved measurement techniques are crucial for developing next-generation tau biomarkers.
- Tau seed detection holds potential for personalized medicine approaches in neurodegenerative diseases.
